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care systems and in the open marketplace. With prospects for the 
powerful combination of neuroimaging with other modalities such 
as genetics and molecular pharmacology, there is an even greater 
need for rigorous exploration of the ethical dimensions of research 
at present and on the horizon (Tairyan and Illes, 2009; Buchman 
and Illes, 2010).
Here we sought to characterize the landscape of ethics in neu-
roimaging as one domain of neuroscience. Using North America 
as a starting point, we asked principal investigators (PIs) and 
faculty members whose work specifically involves brain imaging 
and stimulation, and their students and professional staff, what 
they view as key challenges related to ethics in their work, what 
motivates them to give consideration to those issues, and the bar-
riers to do so beyond the requirements for institutional approval 
in research.
Materials and Methods
We invited 1200 PIs based in the United States and Canada whose 
research involves electrophysiology (e.g., electroencephalography 
[EEG]), magnetic resonance imaging (MRI and functional MRI), 
magnetoencephalography (MEG), positron and single photon 
emission tomography (PET and SPECT), optical imaging (NIR), 
deep brain stimulation (DBS), transcranial magnetic stimulation 
(TMS), or imaging genetics to participate in an online survey. PIs 
were identified through searchable databases of federally funded 
research grants of the US-based National Institutes of Health (NIH, 
Computer Retrieval of Information on Scientific Projects [CRISP]), 
the Canadian Institute of Health Research (CIHR), the Natural 
Sciences and Engineering Research Council of Canada (NSERC), 
and the Social Sciences and Humanities Research Council of 
Canada (SSHRC). To capture responses from investigators with 
current research activity, we restricted the search to grants awarded 
between 2007 and 2009 inclusive. Researchers were asked to forward 
the invitation to participate on to others in their research team 
introduction
Ethics is a growing interest for neuroscientists but is also battling a 
bad reputation that it cannot seem to shake. Rather than signifying 
a commitment to the protection of human subjects, care of animals, 
and public understanding to which the professional community is 
engaged in a fundamental way, interest in the moral underpinnings 
of research has been overtaken by administrative overhead and the 
mission creep of institutional ethics reviews beyond their original, 
intended goals (Gunsalus et al., 2006). Regulation and obligation 
have taken the breath out of researcher good will and compromised 
efforts to integrate fully societal concerns and potential implica-
tions of new research results upstream into the experimental proc-
ess. This disconnect has important consequences for brain research, 
as advances in neuroscience are having a more direct impact on the 
understanding of and approach to brain health and brain disease 
than ever before (Hyman, 2004).
The obligation to take note of societal implications of neu-
roscience has been expressed in a growing number of publica-
tions (Caplan, 2002; Illes and Racine, 2005; Leshner, 2005; Illes, 
2006; Illes and Bird, 2006; Garnett et al., 2010), in professional 
conferences and the explicit integration of lectures and symposia 
at the Society for Neuroscience (SfN), Federation of European 
Neuroscience Societies (FENS), the Organization of Human Brain 
Mapping (OHBM), and the American Academy of Neurology 
(AAN), and through the development of professional societies 
(e.g., Neuroethics Society www.http://neuroethicssociety.org, and 
the Society for Social Neuroscience www.http://s4sn.org) devoted 
to these issues.
Within the broad domain of brain research, imaging is an impor-
tant focus for these discussions as new results have informed how 
people think, make decisions and hold beliefs, have brought new 
meaning to old diagnostic categories in neurology and mental 
health, have affected medical–legal decision-making, and opened 
new doors to personalized medicine both within traditional health 
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for their voluntary and anonymous participation. Approval for 
this study was obtained from the University of British Columbia 
Behavioral Research Ethics Board.
With an online survey containing 45 questions (please see 
Supplementary material), we probed investigators on the relative 
importance of ethics issues they encounter in their work, and what 
motivates and prevents them from incorporating ethics into their 
research. Answers were given based on a five-point Likert scale 
with opportunity for augmenting the quantitative responses with 
free-text, narrative content. We used exploratory factor analysis 
to transform the original questionnaire items into a smaller set 
of factors, reducing the dimensionality of the data and achieving 
meaningful interpretations about ethics constructs in neuroimag-
ing. We applied factor analysis with a varimax rotation separately on 
the items addressing ethical issues, motivators and barriers. In each 
case, the number of factors was chosen based on the Kaiser rule of 
retaining all factors with a corresponding eigenvalue greater than 
1. Sampling adequacy was assessed using the Kaiser–Meyer–Olkin 
(KMO) test that, for each of the three cases, was over 0.8. Bartlett’s 
method was used to obtain unbiased estimates of the factor scores 
for each respondent computed as a weighted sum of the original 
variables. We used a linear regression model to understand the 
effect of key variables of interest on the factor scores.
results
respondents
We received 605 responses to the survey from principal investiga-
tors and faculty, postdoctoral fellows, graduate students, and staff: 
47% are female; 42% hold faculty positions, 61% have a PhD and/
or MD degree, and 35% are the head of their research group. Of 
the cohort of responders, 81% report that their studies involve 
human subjects only, 5% involve non-human primates and other 
animals, and the remainder use two or more models. The majority 
of respondents use functional MRI (79%) alone or in combination 
with other techniques.
ethics-related issues
Key ethics-related issues reported by the overall group cluster into 
four factors (Table 1): 1. confidentiality and consent (14.2% of vari-
ance), 2. external forces on academic productivity (13.5% of vari-
ance), 3. conflict of interest (11% of variance), and 4. vulnerability 
and expectations (8% of variance). The first effect we note from 
the regression analysis with these factors (Table 2) is for respond-
ents who expressed a high interest in ethics and a high satisfaction 
with available ethics resources: they view challenges involving con-
fidentiality and consent as more important than respondents in 
the reference categories (no interest in ethics; no satisfaction with 
ethics resources; t(520) = 2.08, p < 0.05; t(520) = 2.57, p < 0.05). 
Postdoctoral fellows view confidentiality and consent as a less 
important ethics challenge than faculty (t(520) = −2.07, p < 0.05); 
the inverse is the case for staff (t(520) = 2.36, p < 0.05). Women 
researchers rate the importance of matters related to recruitment, 
confidentiality, and privacy of human subjects more highly than 
men (t(520) = 2.37, p < 0.05) and are relatively less concerned with 
conflict of interest (t(520) = −4.07, p < 0.01). We observe a similar 
positive effect for women neuroimagers related to the recruitment 
of vulnerable populations, expectations of subjects, and incidental 
findings (t(520) = 3.21, p < 0.01). For this effect, the finding is 
the inverse for both staff (t(520) = −2.11, p < 0.05) and students 
(t(520) = −2.40, p < 0.05) compared to faculty.
Motivators
Key motivators for considering ethics issues in neuroimaging cluster 
into five groups (Table 1): 1. external factors (16% of variance), 2. 
trust and reciprocity (15% of variance), 3. requirements (12% of 
variance), 4. virtue (10% of variance), and 5. communication (8% 
of variance). Faculty are more motivated to consider ethics issues by 
the factor we called virtue than postdoctoral fellows (t(538) = 2.74, 
p < 0.01) and students (t(538) = 2.69, p < 0.01). Female research-
ers value trust and reciprocity more than their male counterparts 
(t(538) = 4.48, p < 0.01). Postdoctoral fellows (t(538) = 4.24, p < 0.01), 
staff (t(538) = 5.22, p < 0.01) and students (t(538) = 5.02, p < 0.01) 
are motivated by external factors such as professional advancement, 
institutional encouragement, and publication success. Respondents 
who have access to a local bioethics center (t(538) = 2.00, p < 0.05) 
and those who are satisfied with bioethics resources (t(538) = 2.75, 
p < 0.01) are more motivated by the requirements of their institu-
tions and research sponsors than those who do not. Requirements 
are also a significant factor motivating investigators whose research 
involves brain stimulation (t(538) = 2.65, p < 0.01) compared to 
researchers who use non-invasive techniques.
Barriers
Barriers to incorporating ethics into neuroimaging research cluster into 
four factors: 1. lack of resources (17% of variance), 2. administrative 
burden (15% or variance), 3. indifference (15% of variance), and 4. 
lack of interest (13% of variance). Postdoctoral fellows (t(546) = 2.65, 
p < 0.01), staff (t(546) = 3.41, p < 0.01) and students (t(546) = 3.86, 
p < 0.01) rated indifference as an important barrier compared to fac-
ulty. In addition, men rated indifference to be a more significant bar-
rier than women (t(546) = 2.75, p < 0.01). Administrative burden is a 
considerable barrier for those who use invasive methods in comparison 
to those who do not (t(546) = 2.32, p < 0.05), and for those whose insti-
tutions house a bioethics center (t(546) = 2.79, p < 0.01). Lack of ethics 
resources is a particular barrier for postdoctoral fellows (t(546) = 2.40, 
p < 0.05) and staff (t(546) = 2.04, p < 0.05) compared to faculty.
discussion
Despite the core values of faculty to be good global citizens of 
research, the overall administrative burden of ethics review seem 
to place them at the mercy of the boards to which oversight falls. 
As one respondent commented in the survey:
“The Investigational [sic] Review Board is often a barrier to ethical 
research. […] The time spent by the investigators responding to issues 
raised by the IRB unrelated to ethical issues takes time away from 
ensuring the safety of subjects and often delays the implementation 
of important research” (Respondent #103).
Another respondent wrote:
“ […] ethics regulations become kind of a running joke since they are 
so complex, take so long to get through, involve so much paperwork 
and regulation, and are sometime[s] almost impossible to follow to 
the level they impose […]” (Respondent #218).
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Table 1 | Exploratory factor analysis of ethics-related issues, motivators and barriers.
N Clusters of factors % of variance Cumulative %  Factor description Factor 
   of variance  loadings
ETHiCs-rElaTEd issuEs
554 Confidentiality 14.2 14.2 Subject confidentiality 0.94 
 and consent
    Privacy of patients/subjects 0.93
    Obtaining informed consent  0.56
 External forces on 13.5 27.7 Priorities of government/public 0.62 
 academic productivity   research sponsors
    Influence of industry sponsorship 0.68 
    on direction and topics
    Opinion of media and stakeholders 0.65
    Effect of patents on publication and 0.51 
    release of data
 Conflict of interest 11.0 38.8 Academic conflict of interest 0.50 
    (e.g., authorship)
    Commercial conflict of interest (e.g., 0.73 
    timing of technology roll out)
 Vulnerability and 8.0 46.7 Recruiting subjects representing 0.56 
 expectations   vulnerable populations
    Unrealistic expectations about 0.68 
    benefits of the research by subjects
    Clinical findings detected unexpectedly 0.50
MoTivaTors 
572 External factors 16.4 16.4 Professional advancement 0.73
    Institutional encouragement 0.69
    Chance of publication success 0.74
    Positive perception by clinicians 0.61
 Trust and reciprocity 15.2 31.6 Direct implications of your research for society 0.53
    Mitigating false hopes or expectations 0.66 
    by subjects
    Better informed public and policies 0.75
    Patients’ right to be informed about 0.72 
    neuroscience advances
 Requirements 12.0 43.6 Requirement by the institution 0.91 
    where you work
    Requirement by research sponsors 0.76
 Virtue 9.5 53.1 Seems like the right thing to do 0.51
    Good citizenship 0.98
 Communication 8.4 61.6 Coverage in the press 0.74
    Positive public perception 0.57
BarriErs
580 Lack of resources 17.2 17.2 Lack of relevant ethics resources 0.84
    Lack of access to colleagues 0.76 
    with ethics expertise
 Administrative burden 15.1 32.3 Increased administrative work 0.66
    Lack of time 0.75
 Indifference 14.6 46.8 Irrelevant to what you do 0.60
    Not your job  0.74
 Lack of interest 13.0 59.9 Lack of individual interest in ethics 0.60
    Lack of interest in ethics among 0.76 
    neuroscience colleagues
Factor analysis is based on complete data for each category; surveys with missing observations were excluded. The three factor analyses (issues, motivators, 
barriers) were fit separately.
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Focus group data from a parallel study mirror such sentiments; 
labeled as “unnecessary”, “complex” and overregulated”, the eth-
ics review process is reported to be taking valuable resources away 
from researchers (Tairyan et al., 2010). Deslauriers et al. (2010) also 
reported a range of practical issues with the ethics review process, 
including the lack of guidance to investigators on the writing of 
informed consent documents, lack of expertise on ethics review 
boards to evaluate neuroimaging protocols, variability between and 
within review boards, and time delays in ethics review. Data from the 
present study suggest that trainees are relatively unaffected by this 
administrative burden and are the most indifferent to ethics issues 
overall. To the extent that they are motivated to think about ethics 
content, that motivation is closely tied to career advancement. A lack 
of resources is a key barrier to engaging this cohort more deeply. 
Local centers devoted to scholarly inquiry in biomedical ethics have 
no measurable effect on the issues, motivators or barriers in neu-
roimaging and, in fact, may be confused with institutional boards 
for ethics review. The source of the gender effect will require further 
study, but may be associated with the leadership and organizational 
skills of women that have been characterized as facilitating positive 
group dynamics and mutual respect (Lewis, 2000; Zielinska, 2010).
We recognize the limitations of this study, including the 18% 
response rate of PIs and the non-randomness of the sample; these 
limitations naturally restrict the generalizability of the results to 
the broader context of neuroscience and even science at large. 
However, in a parallel study of another sector of the neuroscience 
community – investigators whose primary research is focused on 
neurodegenerative diseases – we found similar effects to those we 
report here. Barriers from that study cluster into four familiar fac-
tors: administrative burden, lack of resources, indifference, and lack 
of interest. We found that the lack of ethics resources is a particular 
barrier for senior level investigators in this cohort and for research-
ers who work in the area of drug discovery (Federico et al., 2010). 
Although these were also only North American investigators, the 
data suggest an emerging pattern across neuroscience subspecialty 
categories. We also do not deliver a measure of the degree to which 
the barriers reported are burdensome. Continued empirical work 
of this nature, including studies of larger and international cohorts, 
will clearly expand the knowledge base and solutions to the issues 
highlighted here.
These limitations notwithstanding, there are global strategies to 
overcome the challenges discovered here, and many of them will 
become pressing as neuroimaging increasingly touches the daily lives 
of people, informs social and public policy, and enables more effective 
and albeit potentially more invasive treatments of brain disorders. 
Among these strategies is the development and implementation of a 
new social contract (Samarasekera, 2009) between the neuroscience 
community and institutional review boards that moves these groups 
beyond the mistrust that has built up over time and that has unglued 
meaningful partnership. Ownership of the effort and implementation 
of solutions is a joint responsibility. Better communication between 
ethics committee members and researchers, and within ethics commit-
tees themselves about the mandate of reviewers will streamline ethics 
approval processes. The integration of relevant, culturally appropriate 
curricula early into graduate training will strengthen the ethics knowl-
edge base of young researchers and embed the imperative for ethics in 
their research (Lombera et al., 2010). Collaborations between scholars 
in ethics and in neuroscience must be supported and valued.
Will the implementation of these solutions and others have a positive 
impact on research conduct, outreach to the public, and public trust? 
The upfront investment will be significant and outcomes will need to 
be measured empirically, but we predict that the answer is yes.
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